Literature DB >> 18176354

Adenocarcinoma of Ethmoid: a GETTEC retrospective multicenter study of 418 cases.

Olivier Choussy1, Christophe Ferron, Pierre-Olivier Védrine, Bruno Toussaint, Béatrice Liétin, Patrick Marandas, Emmanuel Babin, Dominique De Raucourt, Emile Reyt, Alain Cosmidis, Marc Makeiff, Danièle Dehesdin.   

Abstract

OBJECTIVE: To determine risk factors and evaluate the treatment of ethmoid adenocarcinoma. Epidemiologic data were recorded and compared with the literature.
MATERIALS AND METHODS: A multicenter and retrospective study. The medical records of 418 patients who had presented with ethmoid adenocarcinoma at 11 French hospitals from 1976 to 2001 were analyzed to determine the clinical characteristics and treatment of the disease.
RESULTS: The gender ratio was 2.8 men per 1 woman. Toxic exposure was classic for this lesion, exposure to wood and leather for most cases. The mean age was 63 years (range 31-91). Symptoms were nonspecific and based on clinical rhinologic signs. Nasal endoscopy after mucosal retraction was found useful to evaluate the extension of the lesion and to perform biopsies. Computed tomography scan and magnetic resonance imagery must be carried out prior to treatment to define extra nasal extension. The survival rate was significantly influenced by the size of the lesion (T4, N+) and extension to brain or dura. Surgery with postoperative radiotherapy remains the treatment of choice. Total excision must be a major priority, as confirmed in our series.
CONCLUSION: This retrospective study was, to our knowledge, the largest ever reported in the literature. This series confirmed the risk factor of this lesion as well as the lesion's influence on the survival rate. Surgery is the most important part of the treatment. Local recurrences were responsible for the poor prognosis of this lesion.

Entities:  

Mesh:

Year:  2008        PMID: 18176354     DOI: 10.1097/MLG.0b013e31815b48e3

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  18 in total

Review 1.  Endoscopic resection of sinonasal cancers.

Authors:  Shirley Y Su; Michael E Kupferman; Franco DeMonte; Nicholas B Levine; Shaan M Raza; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2014-02       Impact factor: 5.075

2.  Establishment and genetic characterization of an immortal tumor cell line derived from intestinal-type sinonasal adenocarcinoma.

Authors:  Jhudit Pérez-Escuredo; Jorge García Martínez; Cristina García-Inclán; Blanca Vivanco; María Costales; César Álvarez Marcos; José Luis Llorente; Mario A Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2011-01-18       Impact factor: 6.730

3.  Differential diagnosis of a carcinoma of the maxillary sinus that resembles a sparganum infection: A case report.

Authors:  Mei-Hong Yu; Chun-Lei Chen; Xiao-Li Liu; Xiao-Wei Xu
Journal:  Exp Ther Med       Date:  2015-07-27       Impact factor: 2.447

4.  Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma.

Authors:  Giuseppe Lombardi; Fable Zustovich; Alessandro Della Puppa; Lucia Borgato; Enrico Orvieto; Renzo Manara; Diego Cecchin; Franco Berti; Patrizia Farina; Marina Paolo Gardiman; Renato Scienza; Vittorina Zagonel
Journal:  J Neurooncol       Date:  2010-12-08       Impact factor: 4.130

5.  Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy.

Authors:  Santiago Cabezas-Camarero; Virginia de la Orden García; Vanesa García-Barberán; Beatriz Mediero-Valeros; Ahmad Issa Subhi-Issa; Patricia Llovet García; Inmaculada Bando-Polaino; Salomé Merino Menéndez; Pedro Pérez-Segura; Eduardo Díaz-Rubio
Journal:  Oncologist       Date:  2019-01-02

Review 6.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

Review 7.  Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review.

Authors:  José Luis Llorente; Jhudit Pérez-Escuredo; César Alvarez-Marcos; Carlos Suárez; Mario Hermsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-17       Impact factor: 2.503

Review 8.  Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.

Authors:  José Luis Llorente; Fernando López; Carlos Suárez; Mario A Hermsen
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

9.  Comparison of endoscopic and external resections for sinonasal instestinal-type adenocarcinoma.

Authors:  Geoffrey Mortuaire; Xavier Leroy; Claire Vandenhende-Szymanski; Dominique Chevalier; Anne-Sophie Thisse
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-30       Impact factor: 2.503

Review 10.  Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma.

Authors:  Antoine Digonnet; Marc Hamoir; Guy Andry; Vincent Vander Poorten; Missak Haigentz; Johannes A Langendijk; Remco de Bree; Michael L Hinni; William M Mendenhall; Vinidh Paleri; Alessandra Rinaldo; Jochen A Werner; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-26       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.